Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | -10.56% | -7.83% | -75.35% |
06-07 | Top Premarket Decliners | MT |
05-10 | Processa Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.35% | 5.14M | |
+48.50% | 780B | |
+41.76% | 627B | |
+19.88% | 334B | |
+6.66% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.57% | 161B | |
-3.46% | 159B |
- Stock Market
- Equities
- PCSA Stock
- News Processa Pharmaceuticals, Inc.
- Maxim Adjusts Price Target on Processa Pharmaceuticals to $5 From $9, Maintains Buy Rating